Cargando…
A Retrospective Study of Stromal Vascular Fraction Cell Therapy for Osteoarthritis
BACKGROUND: Osteoarthritis (OA) is progressive degenerative damage to articular cartilage. Current therapeutic options are reduced to control the OA-associated symptoms, leaving the degenerative changes to progress until a joint replacement becomes mandatory. Therefore, therapeutic alternatives are...
Autores principales: | Mehling, Brian, Hric, Milan, Salatkova, Adriana, Vetrak, Robert, Santora, Doreen, Ovariova, Miriama, Mihalyova, Renata, Manvelyan, Marine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665865/ https://www.ncbi.nlm.nih.gov/pubmed/33224377 http://dx.doi.org/10.14740/jocmr4354 |
Ejemplares similares
-
Case report: Dendritic cell-cytokine induced killer cell therapy in subjects with chronic lymphocytic leukemia and peritoneal cancer
por: Mehling, Brian, et al.
Publicado: (2023) -
Stromal Vascular Fraction in Osteoarthritis of the Knee
por: Jeyaraman, Madhan, et al.
Publicado: (2023) -
Stromal Vascular Fraction for Osteoarthritis of the Knee Regenerative Engineering
por: Ude, Chinedu C., et al.
Publicado: (2022) -
Therapeutic applications of adipose-derived stromal vascular fractions in osteoarthritis
por: Tang, Qi, et al.
Publicado: (2022) -
Stromal vascular fraction therapy for knee osteoarthritis: a systematic review
por: Boada-Pladellorens, Anna, et al.
Publicado: (2022)